Glucagon-Like Peptide-1 Protects Human Islets against Cytokine-Mediated β-Cell Dysfunction and Death: A Proteomic Study of the Pathways Involved-Reference-Cited by-同舟云学术

Glucagon-Like Peptide-1 Protects Human Islets against Cytokine-Mediated β-Cell Dysfunction and Death: A Proteomic Study of the Pathways Involved

Published:2013-08-26 Issue:9 Volume:12 Page:4193-4206
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Rondas Dieter,Bugliani Marco¹,D’Hertog Wannes,Lage Kasper²³⁴,Masini Mathilde¹,Waelkens Etienne,Marchetti Piero¹,Mathieu Chantal,Overbergh Lut

Affiliation:

1. Department Endocrinology and Metabolism, University of Pisa, via Paradisa 2, 56124 Pisa, Italy

2. Center for Biological Sequence Analysis, Technical University of Denmark, Kemitorvet Building 208, DK-2800 Lyngby, Denmark

3. Pediatric Surgical Research Laboratories, MassGeneral Hospital for Children, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114, United States

4. Harvard Medical School, 25 Shattuck Street, Boston, Massachusetts 02115, United States

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr400527q

Reference56 articles.

1. Cytokine production by islets in health and diabetes: cellular origin, regulation and function

2. Cytokines in the Progression of Pancreaticβ-Cell Dysfunction

3. Inflammatory Process in Type 2 Diabetes: The Role of Cytokines

4. The Human Pancreatic Islet Transcriptome: Expression of Candidate Genes for Type 1 Diabetes and the Impact of Pro-Inflammatory Cytokines

5. Disruption of the γ-Interferon Signaling Pathway at the Level of Signal Transducer and Activator of Transcription-1 Prevents Immune Destruction of β-cells

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double‐blind, placebo‐controlled trial;Diabetes, Obesity and Metabolism;2024-08-27

2. Christensenella minuta, a new candidate next-generation probiotic: current evidence and future trajectories;Frontiers in Microbiology;2024-01-11

3. Incretins beyond type 2 diabetes;Diabetologia;2023-08-08

4. A peripherally restricted cannabinoid-1 receptor inverse agonist promotes insulin secretion and protects from cytokine toxicity in human pancreatic islets;European Journal of Pharmacology;2023-04

5. Gut Molecules in Cardiometabolic Diseases: The Mechanisms behind the Story;International Journal of Molecular Sciences;2023-02-08